Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1041-1050 of 9364

Page
per page
  1. Linezolid
    A5181 Linezolid
    Summary: Antibacterial reagent
      ≥16.85 mg/mL
  2. AS-605240
    A5176 AS-605240
    Target: PI3K
    Summary: Potent and selective PI 3-Kγ inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.28 mg/mL
  3. Ponatinib (AP24534)
    A5467 Ponatinib (AP24534)
     1 Citation
    Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src
    Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor
      ≥53.3 mg/mL
  4. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  5. Tazarotene
    A5710 Tazarotene
    Summary: Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor
  6. SB525334
    A5602 SB525334
    Summary: (TGF-beta1) receptor inhibitor
      ≥34.3 mg/mL
  7. GSK429286A
    A5611 GSK429286A
    Target: ROCK
    Summary: Selective ROCK1/ROCK2 inhibitor
      ≥21.6 mg/mL
  8. Clopidogrel
    A5183 Clopidogrel
    Target: P2Y Receptors
    Summary: P2Y12 receptor antagonist
      ≥20.995 mg/mL
  9. Tenofovir
    A5275 Tenofovir
     1 Citation
    Summary: HIV reverse transcriptase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.38 mg/mL
  10. Vecuronium Bromide
    A5220 Vecuronium Bromide
    Target: AChR
    Summary: Nonpolarizing neuromuscular relaxant
      ≥31.89 mg/mL

Items 1041-1050 of 9364

Page
per page